IDiyas

For the Inventor, By the Inventor

London, United Kingdom

Francine Sternfeld

USPTO Granted Patents = 20

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 141(Granted Patents)


Company Filing History:

goldMedal19 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 35 
 
Merck Sharpe & Dohme Corp.
 patents

Years Active: 1996-2008

Loading Chart...
20 patents (USPTO):Explore Patents
1. 7393858 - Tetrahydropyran compounds as tachykinin antagonists (2008-07-01),
2. 7161006 - Sulphones for inhibition of gamma secretase (2007-01-09),
3. 7060710 - [object Object] (2006-06-13),
4. 6949549 - Imidazolophthalazine derivatives as ligands for GABAA receptors (2005-09-27),
5. 6946461 - Imidazolophthalazine derivatives as ligands for GABAA receptors (2005-09-20),
6. 6613766 - Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa &agr;5 receptors (2003-09-02),
7. 6465462 - Substituted triazolo pyridazine derivatives as inverse agonists of the GABAA&agr;5 receptor subtype (2002-10-15),
8. 6448249 - Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABA&agr;5 ligands (2002-09-10),
9. 6444666 - Triazolopyridazine Derivatives for treating anxiety and enhancing cognition (2002-09-03),
10. 6310203 - Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands (2001-10-30),
11. 6297235 - Triazolopyridazine derivatives for treating anxiety and enhancing cognition (2001-10-02),
12. 6200975 - Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands (2001-03-13),
13. 6025374 - Azetidine, pyrrolidine and piperidine derivatives as 5HT1 receptor (2000-02-15),
14. 5981529 - Substituted indolylpropyl-piperazine derivatives as 5-HT.sub.1D .alpha. (1999-11-09),
15. 5902819 - Triazole derivatives (1999-05-11),

Title: The Innovative Journey of Francine Sternfeld

Introduction: Francine Sternfeld, a prominent inventor based in London, GB, has made significant contributions to the field of pharmaceuticals, holding an impressive portfolio of 20 patents. Her work primarily focuses on the development of novel compounds aimed at addressing critical health issues.

Latest Patents: Sternfeld’s latest innovations include "Tetrahydropyran compounds as tachykinin antagonists," which are designed to treat conditions such as depression, anxiety, and migraine. This invention encompasses compounds of specific formulas and their pharmaceutically acceptable salts, aiming to improve patient outcomes in treating complex neural and emotional disorders. Another noteworthy patent is "Sulphones for inhibition of gamma secretase," which targets the pathways of Alzheimer's disease by inhibiting gamma-secretase, hence providing potential therapeutic options for prevention and treatment.

Career Highlights: Throughout her career, Francine has been associated with leading pharmaceutical companies such as Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. Her endeavors in these organizations reflect her dedication to developing impactful medical solutions that address pivotal healthcare challenges.

Collaborations: In her journey as an inventor, Francine Sternfeld has collaborated with esteemed professionals in her field, including Leslie Joseph Street and Austin John Reeve. These partnerships have helped enhance her research and development efforts, leading to innovative breakthroughs in the pharmaceutical industry.

Conclusion: Francine Sternfeld’s prolific career as an inventor highlights her commitment to advancing medical science through innovation. With a strong portfolio of patented inventions, she continues to pave the way for groundbreaking treatments that stand to benefit countless individuals suffering from various health conditions. As she advances her work, the impact of her contributions will undoubtedly resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…